How to measure AV nodal refractoriness in the presence of verapamil, amiodarone, digoxin, and diltiazem

PACE - Pacing and Clinical Electrophysiology

Volumn 19, Issue 2, 1996, Pages 157-164

  Stark, Gerhard ^a   Kasper, Karin ^a   Schulze Bauer, Christian ^a   Stark, Ulrike ^a   Decrinis, Martin ^a   Tritthart, Helmut A ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

amiodarone; atrioventricular conduction time; digoxin; diltiazem; effective refractory period; verapamil

Indexed keywords

AMIODARONE; DIGOXIN; DILTIAZEM; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CONTROLLED STUDY; DRUG EFFECT; GUINEA PIG; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART MUSCLE REFRACTORY PERIOD; HEART PACING; HEART STIMULATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; MEASUREMENT; NONHUMAN; REGIONAL PERFUSION; STIMULUS RESPONSE;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIOVENTRICULAR NODE; CARDIAC PACING, ARTIFICIAL; DIGOXIN; DILTIAZEM; ELECTROCARDIOGRAPHY; FEMALE; FOURIER ANALYSIS; GUINEA PIGS; HEART RATE; MALE; SIGNAL PROCESSING, COMPUTER-ASSISTED; VERAPAMIL;

EID: 0030051279     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1996.tb03307.x     Document Type: Article

References (27)

1. Roth A, Harrison E, Mitani G, et al. Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation. Circulation 1986; 73:316-324.
2. Lang R, Klein HO, DiSegni E, et al. Verapamil improves exercise capacity in chronic atrial fibrillation: Double blind cross over study. Am Heart J 1983; 105:820-825.
3. Graboys TB, Podrid PJ, Lown B. Efficacy of amiodarone for refractory supraventricular tachyarrhythmias. Am Heart J 1983; 106:870-876.
4. Wit AL, Cranefield PF. Effect of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant atrioventricular nodal tachycardia. Circ Res 1974; 35:413-425.
5. Zipes DP, Prystowsky EN, Heger JJ. Amiodarone: Electrophysiologic actions, pharmacokinetics and clinical effects. J Am Coll Cardiol 1984; 3:1059-1064.
6. Stark G, Windisch M, Haller EM, et al. Acute effects of amiodarone on ultrastructure and electrical activity of isolated guinea pig hearts. Cardiovasc Res 1991; 25:807-814.
7. Atwood JE, Myers JN, Sullivan MJ, et al. Diltiazem and exercise performance in patients with chronic atrial fibrillation. Chest 1988; 93:20-25.
8. McCans JL, Lindenmeyer GE, Munson RG, et al. A dissociation of positive staircase (Bowditch) from ouabain-induced positive inotropism-use of verapamil. Circ Res 1974; 35:439-447.
9. McDonald TF, Pelzer D, Trautwein W. On the mechanism of slow calcium channel block in heart. Pfluegers Arch 1980; 385:175-179.
10. Lee KS, Tsien RW. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nifedipine in single dialysed heart cells. Nature 1983; 302:790-794.
11. Nattel S, Talajic M, Quantz M, et al. Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: Evidence for calcium channel-blocking activity. Circulation 1987; 76:442-449.
12. Moe GK, Mendez R. The action of several cardiac glycosides on conduction velocity and ventricular excitability in the dog heart. Circulation 1951; 4:729-734.
13. Swain HH, Weidner CL. A study of substances which alter intraventricular conduction in isolated dog heart. J Pharmacol Exp Ther 1957; 120:137-146.
14. Denes P, Wu D, Dhingra R, et al. The effects of cycle length on cardiac refractory periods in man. Circulation 1974; 49:32-41.
15. Stark G, Sterz F, Stark U, et al. Frequency-dependent effects of adenosine and verapamil on atrioventricular conduction of isolated guinea pig hearts. J Cardiovasc Pharm 1993; 21:955-959.
16. Stark G, Stark U, Tritthart HA. Assessment of the conduction of the cardiac impulse by a new epicardiac surface and stimulation technique (SST-ECG) in Langendorff perfused mammalian hearts. J Pharmacol Method 1989; 21:195-209.
17. Plomp TA, Wiersinga WM, Maes RAA. Tissue distribution of amiodarone and desethylamiodarone in rats after repeated oral administration of various amiodarone dosages. Drug Res 1985; 35:1805-1810.
18. Gold H, Kwit NT, Otto H, et al. Physiological adaptations in cardiac slowing by digitalis and their bearing on problems of digitalization in patients with auricular fibrillation. J Pharmacol Exp Ther 1939; 67:224-238.
19. Ellenbogen KA, Dias VC, Plumb VJ, et al. A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: A multicenter study. J Am Coll Cardiol 1991; 18:891-897.
20. Salerno DM, Dias VC, Kleiger RE, et al. Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter: The Diltiazem-Atrial Fibrillation/Flutter Study Group. Am J Cardiol 1989; 63:1046-1051.
21. Talajic M, Nattel S. Frequency-dependent effects of calcium antagonists on atrioventricular conduction and refractoriness: Demonstration and characterization in anesthetized dogs. Circulation 1986; 74:1156-1167.
22. Nayebpour M, Billette J, Amellal F, et al. Effects of adenosine on rate-dependent atrioventricular nodal function: Potential roles in tachycardia termination and physiological regulation. Circulation 1993; 88:2632-2645.
23. Billette J, Metayer R, St Vincent M. Selective functional characteristics of rate-induced fatigue in rabbit atrioventricular node. Circ Res 1988; 62:790-799.
24. Hondeghem LM, Snyders DJ. Point of view: Class III antiarrhythmic agents have a lot of potentials but a long way to go: Reduced effectiveness and dangers of reverse use dependence. Circulation 1990; 81:686-690.
25. Colatsky TJ, Follmer CH, Starmer CF. Point of view: Channel specificity in antiarrhythmic drug action: Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 1990; 82:2235-2242.
26. Roden DM, Bennett PB, Snyders DJ, et al. Quinidine delays I sub K activation in guinea pig ventricular myocytes. Circ Res 1988; 62:1055-1058.
27. Anderson KP, Walker R, Dustman T, et al. Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo. Circulation 1989; 79:948-958.